ASPIRE Study: COVID19 and Pregnancy

Vios Fertility Institute is proud to partner with the University of California-San Francisco to make patients aware of the ASPIRE study regarding COVID19 and pregnancy. ASPIRE stands for Assessing Safety of Pregnancy In the Coronavirus Pandemic.

ASPIRE study on COVID19 and pregnancy

ASPIRE is a nationwide prospective cohort study of pregnant women and their offspring during the COVID-19 pandemic. All Society for Assisted Reproductive Technology (SART) member clinics have been invited to share this study information with their pregnant patients, directing patients to register to participate at this website.

From ASPIRE, “The goal of this study is to help understand the spread of COVID-19 infection among pregnant women and how infection might affect the health and wellbeing of pregnant mothers and their babies, particularly when the infection occurs in early pregnancy or without any symptoms. The goal is for this knowledge to inform and empower pregnant women and their healthcare providers to provide the best possible care for their pregnancies and future babies. Also, women and couples planning pregnancies will gain important information to help make decisions for their families.”

ASPIRE is focused on the first trimester, a critical and vulnerable period when all of a baby’s organ systems form and the placenta – the crucial connection between mom and baby – develops.

Currently, there are no data about the effects of COVID19 infections in the first trimester. The ASPIRE study will provide critical information to:

(1) Guide the care of pregnant women
(2) Protect the safety of their babies and families
(3) Help those considering pregnancy in the future understand what it means to be pregnant in this new era

Becoming pregnant at any time is a personal choice and with the added uncertainty of a global pandemic, we realize this decision did not come lightly. We celebrate your pregnancy!

We’re also careful to counsel our patients at every step of their care journey about COVID19 and pregnancy considerations and safety guidelines so that you can feel informed and an active and empowered partner in your care.

Who can join the ASPIRE Study?
Anyone who is over the age of 18 and is between 4 – 10 weeks pregnant. Eligible participants will be compensated financially.

  1. You’ll be asked to:
    1. Submit frequent, quick (<1 minute each) symptom tracking reports using your mobile phone and/or computer.
  2. 2. Collect finger-stick blood samples from home at several points throughout your pregnancy. (A helpful how to video is here.)
  3. 3. Give permission to review medical records related to your pregnancy, delivery and baby’s development.
  4. 4. Complete questionnaires online about your health during your pregnancy and after delivery of your baby.

How to get started:

Visit https://aspire.ucsf.edu/ to learn more and register on their website here.

Do you have additional questions about COVID-19 and fertility treatment at Vios? Click here for our latest update.